|
Hi Bill,If you look at old posts under Vasomedical, I have posted some of the studies, and some other people have place some good info on the company there. Yes shipping EECP will mean revenue/earnings. VASO got a 3.5 million contract to supply 15 EECP machines to Orange County California, out side of clinical tests, I think these were the first machines shipped by VASO. If you look at the volume trading on Vaso, as well as the stock chart, it looks as if this stock is getting a lot of interest. I am a med student, and first got interested in EECP for their prelim studies suggested that EECP increased collateral formation around the heart. I decided to see if there was any info on EECP on the internet, and found Vasomedical. VASO has the paten on EECP, and I am almost positive that they have FDA approval since they already shipped out machines. I think this technology will be great on two fronts. One it may help people prevent cardio disease, two it is a low cost, safer treatment than surgery for angina. I think that Insurence companies and HMO's will show very strong interest in EECP. Right now there is a large scale study being done at Harvard, Yale, COlombia, University of San Fran, and Stoney Brook on EECP. I understand they are going well. I have heard people say that this stock will be 50 in 12 months. I don't agree with them, I think this stock does have potential to reach mid teens though. I think this company is worth the risk, in fact this is the first stock that I have invested in under $10. I think that this technology will be attractive to people who don't want to have surgery, and will allow ins. companies to have a low cost solution to surgery. Do you have any stocks that you recommend? Good Luck, Craig |
